APA (7th ed.) Citation

Lin, P., Teng, W., Jeng, W., Lin, C., Lin, C., Lin, S., & Sheen, I. (2024). Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment. Journal of the Formosan Medical Association, 123(7), 788-795. https://doi.org/10.1016/j.jfma.2024.01.031

Chicago Style (17th ed.) Citation

Lin, Po-Ting, Wei Teng, Wen-Juei Jeng, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin, and I-Shyan Sheen. "Subsequent Locoregional Therapy Prolongs Survival in Progressive Hepatocellular Carcinoma Patients Under Lenvatinib Treatment." Journal of the Formosan Medical Association 123, no. 7 (2024): 788-795. https://doi.org/10.1016/j.jfma.2024.01.031.

MLA (9th ed.) Citation

Lin, Po-Ting, et al. "Subsequent Locoregional Therapy Prolongs Survival in Progressive Hepatocellular Carcinoma Patients Under Lenvatinib Treatment." Journal of the Formosan Medical Association, vol. 123, no. 7, 2024, pp. 788-795, https://doi.org/10.1016/j.jfma.2024.01.031.